CENTESSA PHARMACEUTICALS PLC - AMERICAN DEPOSITARY

Centessa Pharmaceuticals Initiates Global Phase 3 ACTION Study of Lixivaptan in Autosomal Dominant Polycystic Kidney Disease, Reports Initial Positive Safety Data from ALERT Study, and Announces Notice of Allowance for Key Lixivaptan U.S. Patent Application

14 12 2021 06:30:00 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals Announces Addition to NASDAQ Biotechnology Index

13 12 2021 15:15:00 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals Announces Third Quarter 2021 Financial Results and Business Updates

15 11 2021 06:00:03 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals to Present at Upcoming Conferences in 2021

10 11 2021 15:45:00 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals Demonstrates Proof-of-Mechanism from First Three PiMZ Subjects Dosed in Part B of Phase 1 Study Evaluating ZF874

01 11 2021 06:30:00 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals Subsidiary, Orexia Therapeutics, and Schrödinger Announce Collaboration to Discover Novel Orexin Receptor Agonists

18 10 2021 07:00:01 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals Appoints David Grainger, PhD, a Leading Biotech Entrepreneur, as Chief Innovation Officer

05 10 2021 07:00:01 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals Announces $300 Million Financing Agreement with Oberland Capital

04 10 2021 07:00:01 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals Announces Positive Topline Data from Proof-of-Concept Study of SerpinPC in Severe Hemophilia A and B Patients Not on Prophylaxis

09 9 2021 06:30:00 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference

01 9 2021 15:15:00 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals Announces Second Quarter 2021 Financial Results and Business Updates

16 8 2021 06:00:01 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

07 6 2021 15:15:00 提供 Nasdaq GlobeNewswire